These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 26783354)
1. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin. Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354 [TBL] [Abstract][Full Text] [Related]
2. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data. Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331 [TBL] [Abstract][Full Text] [Related]
3. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185 [TBL] [Abstract][Full Text] [Related]
4. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing. Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293 [TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials. Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475 [TBL] [Abstract][Full Text] [Related]
6. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery. Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550 [TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028 [TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG; N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis. Lindquist DE; Stewart DW; Brewster A; Waldroup C; Odle BL; Burchette JE; El-Bazouni H Clin Appl Thromb Hemost; 2018 Nov; 24(8):1315-1321. PubMed ID: 29716395 [TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery. Samama CM; Laporte S; Rosencher N; Girard P; Llau J; Mouret P; Fisher W; Martínez-Martín J; Duverger D; Deygas B; Presles E; Cucherat M; Mismetti P; N Engl J Med; 2020 May; 382(20):1916-1925. PubMed ID: 32223113 [TBL] [Abstract][Full Text] [Related]
11. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital. Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830 [TBL] [Abstract][Full Text] [Related]
12. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement. Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957 [TBL] [Abstract][Full Text] [Related]
13. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin. Yen SH; Lin PC; Kuo FC; Wang JW Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715 [TBL] [Abstract][Full Text] [Related]
14. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. Fuji T; Ochi T; Niwa S; Fujita S J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459 [TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Rivaroxaban in Primary Total Hip and Knee Arthroplasty. Piple AS; Wang JC; Kang HP; Mills ES; Mayfield CK; Lieberman JR; Christ AB; Heckmann ND J Arthroplasty; 2023 Aug; 38(8):1613-1620.e4. PubMed ID: 36805121 [TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W; N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Liu J; Zhao J; Yan Y; Su J Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570 [TBL] [Abstract][Full Text] [Related]
19. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial. ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730 [TBL] [Abstract][Full Text] [Related]
20. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]